MOLECUBES
0644.835.511 · rovalta.com · 22/09/2026
NORMAL SITUATION
MOLECUBES
Financial year 2024 · closed on 31/12/2024
Net result
-652,8 k €
-123.4% YoY
Gross margin
1,5 M €
-70.6% YoY
Equity
7,2 M €
-8.3% YoY
Workforce
19,0 ETP
+15.2% YoY
Company — Normal situation.
Overview
What does MOLECUBES do?
MOLECUBES is a company registered in Belgium. It employs on average 19,0 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0644.835.511
Legal form
Public limited company
Contributed capital
1 173 103,35 €
Latest accounts
31/12/2024
Average workforce
19,0 ETP
Joint committees (2)
- 200
- 20000
Signals
Solid equityGood liquidityHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 9 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||
| Gross margin | 1,5 M € | -70.6% | 5,1 M € | +11.0% | 4,6 M € | +66.7% | 2,8 M € | -6.9% | 3 M € | +66.3% | 1,8 M € | +47.9% | 1,2 M € | +337% | -508,1 k € | -4.7% | -485,4 k € |
| EBITDA | -530,1 k € | -118% | 3 M € | +12.3% | 2,7 M € | +184% | 945,1 k € | -37.3% | 1,5 M € | +79.3% | 841 k € | +64.5% | 511,3 k € | +155% | -921,8 k € | -23.4% | -747 k € |
| Operating result | -679,3 k € | -124% | 2,9 M € | +9.9% | 2,6 M € | +151% | 1 M € | -23.2% | 1,4 M € | +106% | 658,2 k € | +123% | 294,6 k € | +128% | -1,1 M € | -21.6% | -875,9 k € |
| Net result | -652,8 k € | -123% | 2,8 M € | +7.9% | 2,6 M € | +155% | 1 M € | -24.5% | 1,3 M € | +104% | 657,1 k € | +158% | 254,6 k € | +129% | -881,1 k € | -15.5% | -763,1 k € |
| Balance sheet | |||||||||||||||||
| Equity | 7,2 M € | -8.3% | 7,9 M € | +54.6% | 5,1 M € | +103% | 2,5 M € | -16.2% | 3 M € | +80.8% | 1,7 M € | +65.3% | 1 M € | +33.9% | 751,5 k € | +23.1% | 610,5 k € |
| Total assets | 8,9 M € | -10.7% | 10 M € | +42.5% | 7 M € | +66.2% | 4,2 M € | +4.8% | 4 M € | +18.4% | 3,4 M € | +57.7% | 2,2 M € | +25.7% | 1,7 M € | +102% | 846,9 k € |
| Cash | 51,2 k € | -99.0% | 5,2 M € | +38.7% | 3,8 M € | +266% | 1 M € | -52.5% | 2,2 M € | +548% | 333,3 k € | -45.0% | 605,7 k € | +108% | 291,6 k € | +551% | 44,8 k € |
| Debts | 506,1 k € | -48.9% | 990 k € | -27.1% | 1,4 M € | +8.1% | 1,3 M € | +65.2% | 760,6 k € | -52.5% | 1,6 M € | +51.7% | 1,1 M € | +9.6% | 962,9 k € | +307% | 236,4 k € |
| Other | |||||||||||||||||
| Workforce | 19,0 ETP | +15.2% | 16,5 ETP | +4.4% | 15,8 ETP | +11.3% | 14,2 ETP | – | 11,2 ETP | +86.7% | 6,0 ETP | +1.7% | 5,9 ETP | +63.9% | 3,6 ETP | ||
Governance
Board of directors
Seen on filing of 31/12/2024 · 4 active · 19 ended
Active mandates
Ewout Vansteenkiste
ActivePeter Rietman
ActiveWulf-Ingo Jung
ActiveMichael Heidenreich
ActiveEnded mandates
Financials
Annual accounts
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/11/2025 | 06/07/2024 | 12/07/2023 | 28/06/2022 | 06/05/2021 | 02/07/2020 |
| General meeting | 31/10/2025 | 05/07/2024 | 19/06/2023 | 22/06/2022 | 26/04/2021 | 15/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
9 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 31/10/2025 | 13/11/2025 | Dutch | |
| Abridged model | 31/12/2023 | 05/07/2024 | 06/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 19/06/2023 | 12/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 22/06/2022 | 28/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 26/04/2021 | 06/05/2021 | Dutch | |
| Abridged model | 31/12/2019 | 15/06/2020 | 02/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 30/04/2019 | 08/05/2019 | Dutch | |
| Abridged model | 31/12/2017 | 24/04/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 24/04/2017 | 29/06/2017 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2024 · 4 active · 19 ended
Active mandates
Ewout Vansteenkiste
ActivePeter Rietman
ActiveWulf-Ingo Jung
ActiveMichael Heidenreich
ActiveEnded mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-652,8 k €↓
- 2023Annual accounts 20232,8 M €↑
- 2022Annual accounts 20222,6 M €↑
- 2022Name changeMolecubes (archived 27/06/2023 - 19:34)
- 2021Annual accounts 20211 M €↓
- 2021Name changeMolecubes
- 2020Annual accounts 20201,3 M €↑
- 2019Annual accounts 2019657,1 k €↑
- 2018Annual accounts 2018254,6 k €↑
- 2017Annual accounts 2017-881,1 k €↓
- 2016Annual accounts 2016-763,1 k €